论文信息 - Anti-CD22 Immunotoxin RFB4(dsFv)-PE38 (BL22) for CD22-Positive Hematologic Malignancies of Childhood: Preclinical Studies and Phase I Clinical Trial - 字舞流文

Anti-CD22 Immunotoxin RFB4(dsFv)-PE38 (BL22) for CD22-Positive Hematologic Malignancies of Childhood: Preclinical Studies and Phase I Clinical Trial

S. Steinberg | I. Pastan | H. Findley | M. Stetler-Stevenson | R. Kreitman | C. Delbrook | A. Wayne | Glen Lew | D. FitzGerald | Cindy P Delbrook | Cindy P. Delbrook